MicroBrightField, Inc. – Trademark Portfolio
Entity Type: 03
MicroBrightField, Inc. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 25 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 15 trademarks are registered. Notable registered marks include LUCIVID, WORMLAB, VESALIUS, BIOLUCIDA, and CELLAIRUS. The owner is based in Williston, VT.
185 Allen Brook Lane, Suite 101
Williston, VT 05495
Showing of trademarks Trademarks
Trademark Classifications
MicroBrightField, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does MicroBrightField, Inc. have?
MicroBrightField, Inc. has 27 U.S. trademarks filed with the USPTO. Of these, 15 registered, 4 abandoned, 8 cancelled.
What trademark classes does MicroBrightField, Inc. file in?
MicroBrightField, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are MicroBrightField, Inc.'s most well-known trademarks?
MicroBrightField, Inc.'s registered trademark portfolio includes well-known marks such as LUCIVID, WORMLAB, VESALIUS, BIOLUCIDA, and CELLAIRUS. These are among 15 currently registered trademarks in the portfolio.
What is MicroBrightField, Inc.'s trademark registration success rate?
MicroBrightField, Inc. has a 56% trademark registration rate, with 15 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.